SCHEMBL26427328

SCHEMBL26427328

C1CNCCN(C2CNC2)C1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.59
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 1/20 0.35
CXCR4 P61073 5/20 0.34
MEN1 O00255 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
ADRA2C P18825 1/20 0.31
CCR2 P41597 1/20 0.31
CXCL12 P48061 1/20 0.31
BLM P54132 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
ALDH1A1 P00352 1/20 0.30
L3MBTL3 Q96JM7 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25045105 0.93 HTR6 (0.68) HTR6KMT2ASMN1; SMN2HPGDCXCR4
SCHEMBL5071333 0.90 HTR6 (0.56) HTR6KMT2ASMN1; SMN2HPGD
SCHEMBL24684499 0.85 HTR6 (0.70) HTR6KMT2ASMN1; SMN2HPGDCXCR4
SCHEMBL64117 0.83 HTR6 (0.56) HTR6KMT2ASMN1; SMN2HPGDCXCR4
SCHEMBL2904654 0.83 HTR6 (0.56) HTR6KMT2ASMN1; SMN2HPGDCXCR4
SCHEMBL337087 0.82 HTR6 (0.65) HTR6KMT2ASMN1; SMN2HPGD
SCHEMBL3056808 0.82
SCHEMBL3810047 0.82
Hydrochloric Acid SCHEMBL2973444 0.81 HTR6 (0.54) HTR6KMT2ASMN1; SMN2HPGDCXCR4
SCHEMBL1507120 0.81 HTR6 (0.65) HTR6KMT2ASMN1; SMN2HPGDCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067353-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 WO disclosed